{"id":160871,"date":"2024-05-06T14:46:39","date_gmt":"2024-05-06T18:46:39","guid":{"rendered":"https:\/\/44.250.171.167\/?p=160871"},"modified":"2024-05-06T14:46:40","modified_gmt":"2024-05-06T18:46:40","slug":"lupin-ltd-q4fy24-52-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/lupin-ltd-q4fy24-52-rise-in-profits\/","title":{"rendered":"Lupin Ltd Q4FY24; 52% rise in Profits"},"content":{"rendered":"\n<p>Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Financial Results:<\/h2>\n\n\n\n<p>Lupin Ltd reported Revenues for Q4FY24 of \u20b94,961.00 Crores up from \u20b94,430.00 Crore year on year, a rise of 11.99%.<\/p>\n\n\n\n<p>Total Expenses for Q4FY24 of \u20b94,492.00 Crores up from \u20b94,209.00 Crores year on year, a rise of 6.72%.<\/p>\n\n\n\n<p>Consolidated Net Profit of \u20b9368.00 Crores up 52.07% from \u20b9242.00 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is \u20b97.89, up 52.02% from \u20b95.19 in the same quarter of the previous year.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36-839x1024.png\" alt=\"\" class=\"wp-image-160872\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions. Financial Results: Lupin Ltd reported [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":160872,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[11463,12565,1115],"class_list":["post-160871","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-biotech-pharma","tag-generic-formulation","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":166808,"url":"https:\/\/alphastreet.com\/india\/lupin-ltd-q3fy25-39-rise-in-profits\/","url_meta":{"origin":160871,"position":0},"title":"Lupin Ltd Q3FY25; 39% rise in Profits","author":"Chirag Gupta","date":"February 12, 2025","format":false,"excerpt":"Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168697,"url":"https:\/\/alphastreet.com\/india\/lupin-ltd-q4fy25-112-rise-in-profits\/","url_meta":{"origin":160871,"position":1},"title":"Lupin Ltd Q4FY25; 112% rise in Profits","author":"Chirag Gupta","date":"June 6, 2025","format":false,"excerpt":"Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":163810,"url":"https:\/\/alphastreet.com\/india\/lupin-ltd-q1fy25-78-rise-in-profits\/","url_meta":{"origin":160871,"position":2},"title":"Lupin Ltd Q1FY25; 78% rise in Profits","author":"Chirag Gupta","date":"August 13, 2024","format":false,"excerpt":"Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":145655,"url":"https:\/\/alphastreet.com\/india\/lupin-limited-q4fy23-earnings-story\/","url_meta":{"origin":160871,"position":3},"title":"Lupin Limited Q4FY23 Earnings Story","author":"Karan_Singh","date":"May 10, 2023","format":false,"excerpt":"Lupin manufactures pharmaceuticals as a line of business. Globally, APIs, biotechnology products, and generic formulations are all developed and marketed by Lupin Limited. The firm\u00a0is a worldwide leader in the Anti-TB and Cephalosporins segments and has a substantial presence in the Cardiovascular, Diabetology, Asthma, Paediatrics, and Central Nervous system markets,\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":151230,"url":"https:\/\/alphastreet.com\/india\/lupin-ltd-q1fy24-29-rise-in-revenue\/","url_meta":{"origin":160871,"position":4},"title":"Lupin Ltd Q1FY24; 29% rise in Revenue","author":"Karan_Singh","date":"August 4, 2023","format":false,"excerpt":"Lupin is engaged in the business of Manufacture of Pharmaceuticals. Financial Results: Lupin Ltd reported Revenues for Q1FY24 of \u20b94,814.00 Crores up from \u20b93,744.00 Crore year on year, a rise of 28.58%. Total Expenses for Q1FY24 of \u20b94,279.00 Crores up from \u20b93,748.00 Crores year on year, a rise of 14.17%.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161623,"url":"https:\/\/alphastreet.com\/india\/torrent-pharmaceuticals-ltd-q4fy24-56-rise-in-profits\/","url_meta":{"origin":160871,"position":5},"title":"Torrent Pharmaceuticals Ltd Q4FY24; 56% rise in Profits","author":"Chirag Gupta","date":"May 25, 2024","format":false,"excerpt":"Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. Financial Results: Torrent Pharmaceuticals Ltd reported Revenues for Q4FY24 of \u20b92,745.00 Crores up from \u20b92,491.00 Crore year on year, a rise of 10.2%. Total Expenses for Q4FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/160871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=160871"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/160871\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/160872"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=160871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=160871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=160871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}